We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

0K6R Neurocrine Biosciences Inc

0.00 (0.0%)
08 Dec 2023 - Closed
Delayed by 15 minutes

Neurocrine Biosciences Financial Summary

The current 0K6R market cap is 9.01B. The company's latest EPS is USD 1.5725 and P/E is 74.57.

Year End 31 December 2022 20182019202020212022
Total Revenue 451.24M788.09M1.05B1.13B1.49B
Operating Income 36.9M72.28M163M102.5M249M
Net Income 21.11M37.01M407.3M89.6M154.5M
Year End 31 December 2022 20182019202020212022
Total Assets 993.15M1.31B1.73B2.07B2.37B
Total Liabilities 512.39M669.12M608.5M698.5M660.9M
Total Equity 480.77M636.92M1.13B1.37B1.71B

Cash Flow

Year End 31 December 2022 20182019202020212022
Operating 101.36M152.05M228.5M256.5M339.4M
Investing -242.92M-211.07M4.1M-130.2M-177.1M
Financing 29.53M27.31M-157.8M27.4M-234.3M
Market Cap 9.01B
Price to Earnings Ratio 74.57
Price to Sales Ratio 7.74
Price to Cash Ratio 43.82
Price to Book Ratio 6.75
Dividend Yield -

Share Statistics

Shares Outstanding 98.25M
Average Volume (1 week) 238
Average Volume (1 Month) 115
52 Week Change 0.0%
52 Week High 91.67
52 Week Low 91.67
Spread (Intraday) 0 (0%)

Company Info

Company Name Neurocrine Biosciences Inc
Address 251 little falls drive
wilmington, delaware 19808
Industry biological pds,ex diagnstics (2836)

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 |